Working… Menu

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept (MAZERATI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02353780
Recruitment Status : Unknown
Verified August 2017 by Dr. Larry W. Moreland, University of Pittsburgh.
Recruitment status was:  Active, not recruiting
First Posted : February 3, 2015
Last Update Posted : June 3, 2019
Genentech, Inc.
Bristol-Myers Squibb
Information provided by (Responsible Party):
Dr. Larry W. Moreland, University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : July 2019